ロード中...
Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β(2)-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury
A hallmark of the progressive cascade of damage referred to as secondary spinal cord injury (SCI) is vascular disruption resulting in decreased oxygen delivery and loss of mitochondria homeostasis. While therapeutics targeting restoration of single facets of mitochondrial function have proven largel...
保存先:
| 出版年: | J Neurotrauma |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc., publishers
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484358/ https://ncbi.nlm.nih.gov/pubmed/30280980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/neu.2018.5669 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|